(Q47778081)

5 February 2018

title

CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. (English)

1 reference

5 February 2018

1 reference

Richard Aplenc

1

1 reference

5 February 2018

Wendy Glatfelter

2

1 reference

5 February 2018

Peggy Han

3

1 reference

5 February 2018

Eric Rappaport

4

1 reference

5 February 2018

Mei La

5

1 reference

5 February 2018

Avital Cnaan

6

1 reference

5 February 2018

M Anne Blackwood

7

1 reference

5 February 2018

Beverly Lange

8

1 reference

5 February 2018

Timothy Rebbeck

9

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

5 February 2018

British Journal of Haematology

published in

1 reference

5 February 2018

volume

122

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

240-244

1 reference

5 February 2018

Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Controlling the false discovery rate in behavior genetics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Association of CYP3A4 genotype with treatment-related leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Pharmacogenetics and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Differential bone marrow aspirate DNA yields from commercial extraction kits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

Acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04430.X

10.1046/J.1365-2141.2003.04430.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

12846892

1 reference

5 February 2018